[1] Aguilar M, Bhuket T, Torres S, et al. Prevalence of the meta-bolic syndrome in the United States, 2003-2012. JAMA, 2015; 313, 1973-4. doi:  10.1001/jama.2015.4260
[2] Schindhelm RK, Diamant M, Dekker JM, et al. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev, 2006; 22, 437-43. doi:  10.1002/(ISSN)1520-7560
[3] Lu J, Zhang J, Du R, et al. Age at menarche is associated with the prevalence of non-alcoholic fatty liver disease later in life. J Diabetes, 2017; 9, 53-60. doi:  10.1111/1753-0407.12379
[4] Kuzhandai velu V, Jyothirmayi B, Kumar JS. Insulin resistance and alanine amino transaminase (ALT) levels in first degree relatives of type 2 diabetes mellitus. Diabetes Metab Syndr, 2011; 5, 143-7. doi:  10.1016/j.dsx.2012.02.011
[5] Du R, Cheng D, Lin L, et al. Association between serum CA 19-9 and metabolic syndrome:A cross-sectional study. J Diabetes, 2017; 9, 1040-7. doi:  10.1111/1753-0407.12523
[6] Lee Y, Han KD, Jung JJ, et al. Upper Normal Alanine Aminotransferase Range and Insulin Resistance in Korean Adolescents:Korean National Health and Nutrition Examination Survey, 2009-2010. Dig Dis Sci, 2016; 61, 1700-6. doi:  10.1007/s10620-015-4009-x
[7] National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report. Circulation, 2002; 106, 3143-421. doi:  10.1161/circ.106.25.3143
[8] Liu Z, Que S, Xu J, et al. Alanine aminotransferase-old biomarker and new concept:a review. Int J Med Sci, 2014; 11, 925-35. doi:  10.7150/ijms.8951
[9] Sookoian S, Pirola CJ. Alanine and aspartate aminotransferase and glutamine-cycling pathway:their roles in pathogenesis of metabolic syndrome. World J Gastroenterol, 2012; 18, 3775-81. doi:  10.3748/wjg.v18.i29.3775
[10] Schindhelm RK, Dekker JM, Nijpels G, et al. Alanine aminotransferase predicts coronary heart disease events:a 10-year follow-up of the Hoorn Study. Atherosclerosis, 2007; 191, 391-6. doi:  10.1016/j.atherosclerosis.2006.04.006